person · Reporting owner

OBRIEN JAMES J /KY

Disclosed activity across 4 companies

Tapewire entity: 1781
SEC CIK: 0001023582

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
ALBEMARLE CORPALB · Entity 2581	Director	July 01, 2025	July 03, 2025
EASTMAN CHEMICAL COEMN · Entity 1780	Director	October 07, 2026	October 09, 2026
WESCO INTERNATIONAL INCWCC · Entity 3330	Director	February 16, 2017	February 21, 2017

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ALBEMARLE CORP

Report date July 01, 2025 · Filed July 03, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	8,085	Ending reported balance After 2025-07-01 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2025-07-01 · Grant · Acquired 2,725 · Balance 8,048 F1: Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2026. Row 2 · 2025-07-01 · Grant · Acquired 37 · Balance 8,085 F2: Represents dividends accrued on shares underlying an award granted on July 1, 2024, that vested in full on July 1, 2025, which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2026.

F2: Represents dividends accrued on shares underlying an award granted on July 1, 2024, that vested in full on July 1, 2025, which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan.

EASTMAN CHEMICAL CO

Report date October 07, 2026 · Filed October 09, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	19,159	Reported balance After 2026-10-07 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-10-07 · Grant · Acquired 480 · Balance 19,159 F1: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash. F3: Includes units credited since April 8, 2026, as reinvestment of dividend equivalents for phantom shares deferred under the Directors' Deferred Compensation Plan ("DDCP"), including credits for accrued dividend equivalents that were made to the directors DDCP account on October 7, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director.

F2: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash.

F3: Includes units credited since April 8, 2026, as reinvestment of dividend equivalents for phantom shares deferred under the Directors' Deferred Compensation Plan ("DDCP"), including credits for accrued dividend equivalents that were made to the directors DDCP account on October 7, 2026.

WESCO INTERNATIONAL INC

Report date February 16, 2017 · Filed February 21, 2017

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	1,689	Reported balance After 2017-02-16 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2017-02-16 · Grant · Acquired 1,689 · Balance 1,689 F1: Each Restricted Stock Unit represents a contingent right to receive one share of WESCO Common Stock. F2: The Restricted Stock Units vest in three years from the date of the grant.

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock Unit represents a contingent right to receive one share of WESCO Common Stock.

F2: The Restricted Stock Units vest in three years from the date of the grant.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

HUMANA INC

Report date April 20, 2023 · Filed April 20, 2023

Section 16 reporting ended · disclosed 2023-04-20. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Humana CommonSEC Table I · non-derivative	IndirectSee Footnote	1,794	Reported balance Holding disclosure · report date 2023-04-20 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 1,794 F4: Includes 380 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/2023. Award will be pro-rated based on completed months served in the current year. F3: Shares held by revocable trust account (March 2015), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	28,925	Reported balance Holding disclosure · report date 2023-04-20 · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · Balance 28,925 F3: Shares held by revocable trust account (March 2015), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock. F1: Annual Director's fee payable in stock units which have been deferred at the election of the reporting person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1) and the total includes the vested portion that was subsequently deferred for years 2013 and later.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	737	Reported balance Holding disclosure · report date 2023-04-20 · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · Balance 737 F2: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Filing footnotes · ownership attribution and instrument terms

F1: Annual Director's fee payable in stock units which have been deferred at the election of the reporting person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1) and the total includes the vested portion that was subsequently deferred for years 2013 and later.

F2: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3: Shares held by revocable trust account (March 2015), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock.

F4: Includes 380 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/2023. Award will be pro-rated based on completed months served in the current year.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 04, 2017 Filed May 8, 2017 19:43 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	1,089	$78.11 Strike: $0.00	$85,061.79	Disclosure SEC source: 0000899243-17-012174 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,269 Underlying: Common Stock · 1,089 shares Expires not disclosed F1 · derivative.exercise_price: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 3, 2018 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F2 · shares: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F2 · price: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F1 · derivative.exercise_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 3, 2018 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 3, 2018 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F1 · derivative.underlying_shares: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 3, 2018 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F3 · balance_after: Includes 1 unit credited since April 3, 2017 as hypothetical reinvestment of dividend equivalents. Read SEC document
April 03, 2017 Filed Apr 5, 2017 13:50 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	377	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-17-009435 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,179 Underlying: Common Stock · 377 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 9 units credited since October 3, 2016 as hypothetical reinvestment of dividend equivalents. Read SEC document
February 16, 2017 Filed Feb 21, 2017 21:27 UTC	WESCO INTERNATIONAL INC WCC · Entity 3330	GrantRestricted Stock Units · Derivative	1,689	$0.00	$0.00	Disclosure SEC source: 0001209191-17-012692 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,689 Underlying: Common Stock · 1,689 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of WESCO Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest in three years from the date of the grant. F2 · derivative.expiration_date: The Restricted Stock Units vest in three years from the date of the grant. Read SEC document
January 03, 2017 Filed Jan 4, 2017 21:47 UTC	HUMANA INC HUM · Entity 1429	GrantHumana Common	761	$0.00	$0.00	Disclosure SEC source: 0000049071-17-000008 · edgar.xml · nonDerivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,361 F3 · balance_after: Includes 761 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2017. Read SEC document
December 09, 2016 Filed Dec 9, 2016 21:13 UTC	WESCO INTERNATIONAL INC WCC · Entity 3330	GrantDeferred Share Units · Derivative	1,087.2897	$43.50	$47,291.67	Disclosure SEC source: 0001209191-16-154388 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,087.2897 Underlying: Common Stock · 1,087.2897 shares Expires not disclosed F1 · security: Deferred Share Units are credited to an account in the reporting person's name maintained by WESCO International. F2 · derivative.exercise_price: Each Deferred Share Unit is the economic equivalent of one share of WESCO International common stock. The Deferred Share Unit Account balance becomes eligible for distribution, only in the form of WESCO International common stock, upon termination of service as a Director. F3 · price: The price is based on the average of the high and low trading prices for WESCO International's common stock as of the first trading day in January of 2016. F2 · derivative.exercise_date: Each Deferred Share Unit is the economic equivalent of one share of WESCO International common stock. The Deferred Share Unit Account balance becomes eligible for distribution, only in the form of WESCO International common stock, upon termination of service as a Director. F2 · derivative.expiration_date: Each Deferred Share Unit is the economic equivalent of one share of WESCO International common stock. The Deferred Share Unit Account balance becomes eligible for distribution, only in the form of WESCO International common stock, upon termination of service as a Director. Read SEC document
October 03, 2016 Filed Oct 4, 2016 21:09 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	448	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-16-030869 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 793 Underlying: Common Stock · 448 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 5 units credited since April 1, 2016 as hypothetical reinvestment of dividend equivalents. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.